ES8601869A1 - Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro - Google Patents

Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro

Info

Publication number
ES8601869A1
ES8601869A1 ES534695A ES534695A ES8601869A1 ES 8601869 A1 ES8601869 A1 ES 8601869A1 ES 534695 A ES534695 A ES 534695A ES 534695 A ES534695 A ES 534695A ES 8601869 A1 ES8601869 A1 ES 8601869A1
Authority
ES
Spain
Prior art keywords
cefuroxime axetil
crystalline cefuroxime
crystalline
mixts
solns
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534695A
Other languages
English (en)
Spanish (es)
Other versions
ES534695A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES534695A0 publication Critical patent/ES534695A0/es
Publication of ES8601869A1 publication Critical patent/ES8601869A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES534695A 1983-07-29 1984-07-27 Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro Expired ES8601869A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320521A GB8320521D0 (en) 1983-07-29 1983-07-29 Chemical process

Publications (2)

Publication Number Publication Date
ES534695A0 ES534695A0 (es) 1985-11-01
ES8601869A1 true ES8601869A1 (es) 1985-11-01

Family

ID=10546505

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534695A Expired ES8601869A1 (es) 1983-07-29 1984-07-27 Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro

Country Status (21)

Country Link
JP (1) JPH0613526B2 (fr)
KR (1) KR910008377B1 (fr)
AT (1) AT392470B (fr)
AU (2) AU582121B2 (fr)
BE (1) BE900241A (fr)
CA (1) CA1265511A (fr)
CH (1) CH662121A5 (fr)
DE (1) DE3427828A1 (fr)
DK (1) DK165505C (fr)
ES (1) ES8601869A1 (fr)
FI (1) FI76808C (fr)
FR (1) FR2549837B1 (fr)
GB (2) GB8320521D0 (fr)
IE (1) IE57726B1 (fr)
IL (1) IL72536A (fr)
NL (1) NL8402372A (fr)
NO (1) NO167292C (fr)
NZ (1) NZ209046A (fr)
PT (1) PT78985B (fr)
SE (1) SE463263B (fr)
ZA (1) ZA845830B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
IT1277426B1 (it) * 1995-08-03 1997-11-10 Acs Dobfar Spa Forma cristallina biodisponibile del cefuroxima axetil
CN1111537C (zh) * 1997-05-15 2003-06-18 第一制糖株式会社 高纯晶形头孢呋辛1－乙酰氧乙酯的制备方法
KR100228264B1 (ko) * 1997-08-02 1999-11-01 김선진 결정형 세푸록심 악세틸의 제조방법
CA2209868C (fr) * 1997-08-15 2001-08-14 Bernard Charles Sherman Compositions pharmaceutiques a base de cefuroxime axetil
IN186539B (fr) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
ATE212638T1 (de) * 1998-02-20 2002-02-15 Fako Ilaclari A S Verfahren zur herstellung vom löslichen kristallinen cefuroxim axetil
IN190849B (fr) 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
AT411996B (de) 2000-09-11 2004-08-26 Sandoz Ag Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes
ITMI20011763A1 (it) * 2001-08-10 2003-02-10 Antibioticos Spa Processo di preparazione di cefuroxime axelite ad elevata purezza
ITMI20011925A1 (it) * 2001-09-14 2003-03-14 Antibioticos Spa Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法
DE102005019458A1 (de) 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1094545A (fr) * 1976-02-16 1981-01-27 Michael Gregson Traduction non-disponible
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
JPS577485A (en) * 1980-06-13 1982-01-14 Takeda Chem Ind Ltd Cephalosporin
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics

Also Published As

Publication number Publication date
FI76808B (fi) 1988-08-31
NZ209046A (en) 1988-02-29
AU3125684A (en) 1985-01-31
GB2145409A (en) 1985-03-27
BE900241A (fr) 1985-01-28
DK366684D0 (da) 1984-07-27
ZA845830B (en) 1986-03-26
ATA244484A (de) 1990-09-15
ES534695A0 (es) 1985-11-01
PT78985A (en) 1984-08-01
GB2145409B (en) 1987-02-18
GB8419202D0 (en) 1984-08-30
NO843055L (no) 1985-01-30
DE3427828A1 (de) 1985-02-14
FR2549837B1 (fr) 1986-12-26
FR2549837A1 (fr) 1985-02-01
IL72536A (en) 1988-01-31
AU3660189A (en) 1989-10-05
JPH0613526B2 (ja) 1994-02-23
DK165505B (da) 1992-12-07
SE8403897D0 (sv) 1984-07-27
DK165505C (da) 1993-04-19
GB8320521D0 (en) 1983-09-01
SE463263B (sv) 1990-10-29
AU582121B2 (en) 1989-03-16
AT392470B (de) 1991-04-10
FI843011A0 (fi) 1984-07-27
PT78985B (en) 1986-10-23
JPS6075484A (ja) 1985-04-27
FI843011A (fi) 1985-01-30
SE8403897L (sv) 1985-01-30
IE841938L (en) 1985-01-29
KR910008377B1 (ko) 1991-10-12
FI76808C (fi) 1988-12-12
KR850001221A (ko) 1985-03-16
DK366684A (da) 1985-01-30
NO167292B (no) 1991-07-15
AU634965B2 (en) 1993-03-11
NO167292C (no) 1991-10-23
NL8402372A (nl) 1985-02-18
IL72536A0 (en) 1984-11-30
CH662121A5 (de) 1987-09-15
IE57726B1 (en) 1993-03-24
CA1265511A (fr) 1990-02-06

Similar Documents

Publication Publication Date Title
ES8601869A1 (es) Un procedimiento para preparar ester 1-acetoxietilico de cefuroxima cristalino, muy puro
AU1615788A (en) Cefuroxime axetil compositions
SG70980A1 (en) Novel 4-arylpiperazines and 4-arylpiperidines
NO895160D0 (no) Mikrobiell fremgangsmaate for fremstilling av immunhemmende antibiotika.
NO911606L (no) Fremgangsmaate for fremstilling av glycidylazidpolymer.
AU2371184A (en) 2-imino-pyrrolidines
ES452650A1 (es) Un procedimiento para preparar un ester de sulfoxido de 3- hidroxi-3-cefem.
YU202786A (en) Process for obtaining coloidic basis gel containing primicine
AU527931B2 (en) Substituted pyrido(1,2-a)pyrimidines
FI934395A (fi) 2-spirocyklopropyl 4-acylcephemi samt foerfarande foer framstaellning daerav
NO159094C (no) Fremgangsmaate for fremstilling av antibiotikum l 17054.
ZA907976B (en) Novel 2-spirocyclopropyl cephalosporin sulfone derivatives and processes for the preparation thereof
GB1547473A (en) Cephalosporin compounds
DE3461378D1 (en) Rifamycins derivatives and preparation and pharmaceutical compositions thereof
AU2240388A (en) Azachromane derivatives
AU570070B2 (en) Dibromobenzylcyclohexylamine compounds for the treatment of infections
NO942218D0 (no) Fremgangsmåte for fremstilling av karbonatsammensetning
AU638829B2 (en) Composition for disinfecting water by the electrochlorination process and use of this composition
AU516917B2 (en) 7-(2,3-dihydrobenzo-5-furanyl)acetamido cephalosporin derivatives
FI873464A (fi) Foerfarande foer framstaellning av antibakteriella 7-oxo-4-tia-1-azabicyklo(3.2.0)hept-2-ene derivat.
JPS57185292A (en) Cephem derivative and manufacture
FI880385A (fi) Substituerade 3-fenyl-7h-tiazolo /3,2-b//1,2,4/-triazin-7-oner, foerfaranden foer deras framstaellning, dessa innehaollande laekemedel och deras anvaendning, samt naogra vid framstaellningen av naemnda foereningar bildade mellanprodukter.
JPS53101365A (en) Peptides
NO890287L (no) Fremstilling av beta-laktam-antibiotika.
ES8107309A1 (es) Un procedimiento de produccion de derivados de 7 -metoxice- falosporina